
Vice President, Development
Posted Jul 11

Posted Jul 11
This is a fully remote position, open to applicants in California.
β’ Provide strategic scientific and operational leadership throughout the development sciences functions that progress genetic disease programs from candidate selection to first-in-human and early clinical development, including:
β’ Nonclinical Pharmacology & DMPK Sciences β’ Lead nonclinical PK/PD strategy encompassing target engagement, pharmacodynamic response, and efficacy.
β’ Supervise in vitro and in vivo ADME and DMPK characterization to aid in candidate selection and IND-enabling packages.
β’ Biomarker Sciences & Development β’ Spearhead biomarker identification as well as the nonclinical-to-clinical biomarker strategy and execution.
β’ Propel clinical biomarker qualifications to establish proof of mechanism and proof of concept.
β’ Clinical Pharmacology & Early Clinical Development β’ Oversee early clinical sciences and development strategy from first-in-human through Phase 2.
β’ Direct clinical pharmacology efforts, including Phase 1 healthy-volunteer and special-population studies.
β’ Quantitative Sciences β’ Lead initiatives across data analytics, pharmacometrics, biostatistics, and data management to inform dose selection and program decisions.
β’ Research Operations β’ Manage nonclinical and translational study execution along with vendor management.
β’ Oversee clinical pharmacology study execution and associated vendor relationships.
β’ Bioanalytical Sciences β’ Guide bioanalytical assay development for PK, biomarkers, and immunogenicity.
β’ Supervise both nonclinical and clinical bioanalytical operations.
β’ Cross-Functional Leadership β’ Collaborate closely with Clinical Development, Global Regulatory Affairs, CMC, and Research to produce integrated development plans and regulatory submissions (pre-IND, IND, FIH, Phase 1/2).
β’ Personally lead the technical work across these functions while remaining close to the science and data, utilizing CROs and external partners to ensure alignment with a lean, hands-on early-stage culture.
β’ Represent development sciences to senior leadership, the board, and external advisors, contributing to portfolio-level prioritization and resource allocation decisions.
β’ PhD, PharmD, MD, or equivalent advanced degree in a relevant scientific field.
β’ At least 12+ years of experience in biopharmaceutical drug development, including significant time in technical leadership roles.
β’ Extensive drug development experience covering nonclinical to early clinical stages, with a proven record of advancing programs into and through first-in-human.
β’ Demonstrated leadership in two or more of the following areas: nonclinical pharmacology/DMPK, biomarkers, clinical pharmacology, quantitative sciences, bioanalytical sciences, or research operations.
β’ Experience in a lean, build-oriented, clinical-stage environment with considerable reliance on CROs and external vendors.
β’ Excels in a hands-on, detail-oriented role and is motivated by driving work directly.
β’ Strong history of cross-functional collaboration with Clinical Development, Regulatory, and CMC.
β’ Patient Days, where we are privileged to hear directly from individuals living with the conditions we aim to impact, learning how we can enhance our efforts throughout the year.
β’ A culture driven by our values: prioritize patients, think independently, embrace radical transparency, value every minute, and let science lead the way.
β’ An unwavering commitment to consistently putting patients first.
β’ A decentralized model that empowers our program teams to concentrate on advancing science and assisting patients.
β’ A workplace where you take ownership of the vision β both for your program and your own career trajectory.
β’ A collaborative, fast-paced, data-driven environment that motivates us to consistently perform at our highest level.
β’ Access to learning and development resources to help you achieve your best professional self.
β’ Comprehensive and competitive compensation & benefits package (Base salary, Performance Bonus, Equity, health, welfare & retirement programs).
β’ Flexible PTO.
β’ Opportunities for rapid career advancement for high performers.
β’ Potential to engage in multiple GondolaBio Pharma programs across various therapeutic areas over time.
β’ A commitment to Diversity, Equity & Inclusion.
Coastal
Agiliti
Brown & Brown Insurance
Milo's Tea Company, Inc.
Get handpicked remote jobs straight to your inbox weekly.